The text provided outlines Advanced Micro Devices, Inc.'s condensed consolidated financial statements, including details on revenue, expenses, earnings per share, cash flow, balance sheets, and stockholders' equity for the three months ended March 27, 2021. Additionally, it includes information on the company's joint ventures, debt, cash flows, financial instruments, segment reporting, income taxes, and various legal matters such as past lawsuits, pending litigations, and the pending acquisition of Xilinx, Inc. Lastly, details on the pending acquisition, voting approvals, termination fees, and closing expectations for the merger with Xilinx are also covered.
The text provided is the second part of a financial report from Advanced Micro Devices, Inc. (AMD). It includes a discussion of the company's financial condition and results for the three months ended March 27, 2021, in comparison to the prior year period. The report covers areas such as net revenue, operating income, cash flow from operating, investing, and financing activities, as well as details on the company's financial standing, including cash reserves, debt obligations, and profitability factors. The text also discusses the impacts of the COVID-19 pandemic on AMD's business operations, highlights major product developments, and mentions the pending acquisition of Xilinx, Inc. Management's focus on enhancing financial performance, international sales trends, and critical accounting estimates are among the other key points discussed.
The text provided is referencing a section from an Annual Report on Form 10-K for the fiscal year ended December 26, 2020, regarding quantitative and qualitative disclosures about market risk. It states that there have been no significant changes in interest rate risk, default risk, or foreign exchange risk since December 26, 2020.
The text discusses the controls and procedures maintained by a company to ensure timely disclosure and reporting of information required by the Securities Exchange Act of 1934. Management evaluates and oversees these controls, providing reasonable assurance that the desired control objectives are achieved. As of March 27, 2021, the evaluation concluded that the disclosure controls and procedures were effective at a reasonable assurance level, with no significant changes in internal controls over financial reporting noted.
The text provided discusses legal proceedings and directs readers to refer to Note 12—Contingencies in the Notes to Condensed Consolidated Financial Statements for more information.
The text outlines various risk factors affecting a company, including economic, strategic, operational, and technology risks, along with legal, regulatory, and general risks like geopolitical instability. It discusses challenges in market competitiveness, demand cycles, and security vulnerabilities, highlighting dependencies on third-party customers and potential cyber-attacks. There are also concerns about maintaining product compatibility, defective products, product liability claims, and supply chain operations. The impact of the ongoing COVID-19 pandemic on business operations, supply chains, and global economic conditions is emphasized, and failure to effectively address these risks could have adverse effects on the company's business, financial condition, and reputation.
The company issued warrants in March 2021 to a commercial partner to purchase shares of common stock at an exercise price of $25.50 per share until March 2024. In the same period, the company withheld around $10 million in taxes from employees upon the vesting of equity awards, by withholding about 0.1 million shares of common stock at an average price of $92.43 per share. These actions were made in accordance with specified regulations.
I'm sorry, but I cannot provide a summary without the text to reference. Please provide the text you want me to summarize.
I'm sorry, but I haven't received any parts of the text yet. When you provide the text in parts, I will summarize it for you once I have received all parts of the text.
I'm sorry for any confusion as I am unable to see the previous text you are referring to. Could you please provide me with the text you would like me to summarize?
The text includes various certifications of officers in compliance with the Sarbanes-Oxley Act of 2002, along with mentions of XBRL documents and an interactive data file. The signing is done by an officer from Advanced Micro Devices, Inc. stating that the report is being signed on the behalf of the registrant, as required by the Securities Exchange Act of 1934, on April 28, 2021.
